Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Sutherland RK"'
Autor:
Chadwick, DR1 davidr.chadwick@nhs.net, Sutherland, RK2, Raffe, S3, Pool, ERM4, Beadsworth, MBJ5
Publikováno v:
HIV Medicine. Dec2020 Supplement s5, Vol. 21, p1-19. 19p.
Autor:
Swanson, PA, Padilla, M, Hoyland, W, McGlinchey, K, Fields, PA, Bibi, S, Faust, SN, McDermott, AB, Lambe, T, Pollard, AJ, Durham, NM, Kelly, EJ, AstraZeneca/Oxford/VRC Study Group, Adlou, S, Aley, PK, Angus, B, Anslow, R, Baker, P, Bansal, H, Beveridge, A, Bridges-Webb, A, Ching, S, Cicconi, P, Clutterbuck, EA, Collins, AM, Darton, TC, Demissie, T, Dinesh, T, Douglas, AD, Duncan, CJA, Ewer, KJ, Felle, S, Ferreira, DM, Folegatti, PM, Fuskova, M, Gaudinski, M, Gilbert, SC, Goodman, AL, Gordon, I, Green, CA, Harbolick, E, Hayes, S, Hill, AVS, Hill, H, Jenkin, D, Jepson, BM, Kasanyinga, M, Libri, V, Lillie, PJ, McGregor, AC, Minassian, AM, Mujadidi, YF, Novik, L, Payne, R, Pilataxi, F, Plested, E, Provstgaard-Morys, S, Ramasamy, M, Robinson, H, Sanders, K, Smith, A, Snape, MD, Song, R, Sutherland, RK, Thomson, EC, Toshner, M, Turner, DPJ, Voysey, M, Widge, AT, Williams, CJ
AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::993e6e80c4502ef8c2b6b487068309ee
https://eprints.whiterose.ac.uk/178925/1/scitranslmed.abj7211.pdf
https://eprints.whiterose.ac.uk/178925/1/scitranslmed.abj7211.pdf
Autor:
Feng, S, Phillips, DJ, White, T, Sayal, H, Aley, PK, Bibi, S, Dold, C, Fuskova, M, Gilbert, SC, Hirsch, I, Humphries, HE, Jepson, B, Kelly, EJ, Plested, E, Shoemaker, K, Thomas, KM, Vekemans, J, Villafana, TL, Lambe, T, Pollard, AJ, Voysey, M, Adlou, S, Allen, L, Angus, B, Anslow, R, Asselin, M-C, Baker, N, Baker, P, Barlow, T, Beveridge, A, Bewley, KR, Brown, P, Brunt, E, Buttigieg, KR, Camara, S, Charlton, S, Chiplin, E, Cicconi, P, Clutterbuck, EA, Collins, AM, Coombes, NS, Clemens, SAC, Davison, M, Demissie, T, Dinesh, T, Douglas, AD, Duncan, CJA, Emary, KRW, Ewer, KJ, Felle, S, Ferreira, DM, Finn, A, Folegatti, PM, Fothergill, R, Fraser, S, Garlant, H, Gatcombe, L, Godwin, KJ, Goodman, AL, Green, CA, Hallis, B, Hart, TC, Heath, PT, Hill, H, Hill, AVS, Jenkin, D, Kasanyinga, M, Kerridge, S, Knight, C, Leung, S, Libri, V, Lillie, PJ, Marinou, S, McGlashan, J, McGregor, AC, McInroy, L, Minassian, AM, Mujadidi, YF, Penn, EJ, Petropoulos, CJ, Pollock, KM, Proud, PC, Provstgaard-Morys, S, Rajapaska, D, Ramasamy, MN, Sanders, K, Shaik, I, Singh, N, Smith, A, Snape, MD, Song, R, Shrestha, S, Sutherland, RK, Thomson, EC, Turner, DPJ, Webb-Bridges, A, Wrin, T, Williams, CJ
Publikováno v:
Nature Medicine
The global supply of COVID-19 vaccines remains limited. An understanding of the immune response that is predictive of protection could facilitate rapid licensure of new vaccines. Data from a randomized efficacy trial of the ChAdOx1 nCoV-19 (AZD1222)
Publikováno v:
Journal of Clinical Urology; Jan2013, Vol. 6 Issue 1, p20-21, 2p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Neuhoff J; Center for Spinal Surgery and Neurotraumatology, Berufsgenossenschaftliche Unfallklinik Frankfurt am Main, Frankfurt am Main, Germany.; Spondylodiscitis Study Group, EANS Spine Section, Brussels, Belgium., Kramer A; Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany.; Spondylodiscitis Study Group, EANS Spine Section, Brussels, Belgium., Thavarajasingam SG; Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany.; Imperial Brain & Spine Initiative, Imperial College London, London, UK.; Spondylodiscitis Study Group, EANS Spine Section, Brussels, Belgium., Sutherland RK; Department of Infectious Diseases, Western General Hospital, Edinburgh, UK., McCaughan H; Department of Infectious Diseases, Western General Hospital, Edinburgh, UK., Joerger AK; Department of Neurosurgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Wostrack M; Department of Neurosurgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Lyell B; Medical School, University of Edinburgh, Edinburgh, UK., Berkulian O; Center for Spinal Surgery and Neurotraumatology, Berufsgenossenschaftliche Unfallklinik Frankfurt am Main, Frankfurt am Main, Germany., Ponniah HS; Medical School, University of Edinburgh, Edinburgh, UK.; Faculty of Medicine, Imperial College London, London, UK.; Imperial Brain & Spine Initiative, Imperial College London, London, UK., Ramsay DSC; Medical School, University of Edinburgh, Edinburgh, UK.; Faculty of Medicine, Imperial College London, London, UK.; Imperial Brain & Spine Initiative, Imperial College London, London, UK., Meyer B; Department of Neurosurgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Kandziora F; Center for Spinal Surgery and Neurotraumatology, Berufsgenossenschaftliche Unfallklinik Frankfurt am Main, Frankfurt am Main, Germany., Shiban E; Department of Neurosurgery, Universitätsklinikum Augsburg, Augsburg, Germany.; Spondylodiscitis Study Group, EANS Spine Section, Brussels, Belgium., Davies B; Department of Academic Neurosurgery, Addenbroke's Hospital, Cambridge University Hospital NHS Healthcare Trust, Cambridge, UK.; Spondylodiscitis Study Group, EANS Spine Section, Brussels, Belgium., Demetriades AK; Edinburgh Spinal Surgery Outcome Studies Group, Department of Neurosurgery, Royal Infirmary Edinburgh, NHS Lothian, Edinburgh, UK.; Spondylodiscitis Study Group, EANS Spine Section, Brussels, Belgium., Ringel F; Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany.; Spondylodiscitis Study Group, EANS Spine Section, Brussels, Belgium.
Publikováno v:
Neurosurgery [Neurosurgery] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.
Autor:
Russell CD; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.; Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK., Tsang SJ; The Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford, UK.; Department of Orthopaedic Surgery, University of Edinburgh, Edinburgh, UK., Dudareva M; The Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford, UK., R W Simpson AH; Department of Orthopaedic Surgery, University of Edinburgh, Edinburgh, UK., Sutherland RK; Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK., McNally MA; The Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford, UK.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2023 May 26; Vol. 10 (6), pp. ofad291. Date of Electronic Publication: 2023 May 26 (Print Publication: 2023).
Autor:
Lee NE; Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK., Sutherland RK
Publikováno v:
Current opinion in infectious diseases [Curr Opin Infect Dis] 2023 Feb 01; Vol. 36 (1), pp. 15-19.
Autor:
Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Golubchik T; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ariani CV; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Angus B; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Blane B; COVID-19 Genomics UK, Department of Medicine, University of Cambridge, Cambridge, UK., Bonsall D; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Cicconi P; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Charlton S; National Infection Service, Public Health England, Salisbury, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Collins AM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Cox T; UK Biocentre, Milton Keynes, UK., Darton TC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Douglas AD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Duncan CJA; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK., Ewer KJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Flaxman AL; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Ferreira DM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Finn A; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Folegatti PM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Fuskova M; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Galiza E; St George's Vaccine Institute, St George's, University of London, London, UK., Goodman AL; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK., Green CM; Clinical BioManufacturing Facility, University of Oxford, Oxford, UK., Green CA; NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Hallis B; National Infection Service, Public Health England, Salisbury, UK., Heath PT; St George's Vaccine Institute, St George's, University of London, London, UK., Hay J; University of Glasgow, Glasgow, UK; Lighthouse Laboratory in Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Hill HC; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Jenkin D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Lazarus R; Severn Pathology, North Bristol NHS Trust, Bristol, UK., Libri V; NIHR UCLH Clinical Research Facility, London, UK; NIHR UCLH Biomedical Research Centre, London, UK., Lillie PJ; Hull University Teaching Hospitals NHS Trust, Hull, UK., Ludden C; COVID-19 Genomics UK, Department of Medicine, University of Cambridge, Cambridge, UK., Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Minassian AM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., McGregor AC; London Northwest University Healthcare, Harrow, UK., Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Phillips DJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Pollock KM; NIHR Imperial Clinical Research Facility, London, UK; NIHR Imperial Biomedical Research Centre, London, UK., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Smith A; College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital and School, University of Glasgow, Glasgow, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Sutherland RK; Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK., Thomson EC; MRC University of Glasgow Centre for Virus Research, Glasgow, UK; Severn Pathology, North Bristol NHS Trust, Bristol, UK; Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK., Toshner M; Heart Lung Research Institute, Department of Medicine, University of Cambridge, Cambridge, UK; NIHR Cambridge Clinical Research Facility, Cambridge, UK; Cambridge University Hospital and Royal Papworth NHS Foundation Trusts, Cambridge, UK., Turner DPJ; University of Nottingham, Nottingham, UK; Nottingham University Hospitals NHS Trust, Nottingham, UK., Vekemans J; AstraZeneca BioPharmaceuticals, Gaithersburg, MD, USA., Villafana TL; AstraZeneca BioPharmaceuticals, Gaithersburg, MD, USA., Williams CJ; Public Health Wales, Cardiff, UK; Aneurin Bevan University Health Board, Newport, UK., Hill AVS; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Gilbert SC; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: maheshi.ramasamy@paediatrics.ox.ac.uk., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Publikováno v:
Lancet (London, England) [Lancet] 2021 Apr 10; Vol. 397 (10282), pp. 1351-1362. Date of Electronic Publication: 2021 Mar 30.
Autor:
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Costa Clemens SA; Institute of Global Health, University of Siena, Siena, Italy; Department of Paediatrics, University of Oxford, Oxford, UK., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Weckx LY; Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil., Folegatti PM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Angus B; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Baillie VL; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Barnabas SL; Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa., Bhorat QE; Soweto Clinical Trials Centre, Soweto, South Africa., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Briner C; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Cicconi P; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Collins AM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Cutland CL; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Darton TC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Dheda K; Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, Cape Town, South Africa; Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene & Tropical Medicine, London, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Duncan CJA; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK., Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ewer KJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Flaxman A; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Fairlie L; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, University of Southampton, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ferreira DM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Finn A; School of Population Health Sciences, University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust, UK., Galiza E; St George's Vaccine Institute, St George's, University of London, London, UK., Goodman AL; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK., Green CM; Clinical BioManufacturing Facility, University of Oxford, Oxford, UK., Green CA; NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Hill C; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Hill HC; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Hirsch I; AstraZeneca BioPharmaceuticals, Cambridge, UK., Izu A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Jenkin D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Joe CCD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Koen A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Kwatra G; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Lazarus R; Severn Pathology, North Bristol NHS Trust, Bristol, UK., Libri V; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK., Lillie PJ; Department of Infection, Hull University Teaching Hospitals NHS Trust, Hull, UK., Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Marshall RP; AstraZeneca BioPharmaceuticals, Cambridge, UK., Mendes AVA; Escola Bahiana de Medicina e Saúde Pública, Salvador, Braziland Hospital São Rafael, Salvador, Brazil; Instituto D'Or, Salvador, Brazil., Milan EP; Universidade Federal do Rio Grande do Norte, Natal, Brazil., Minassian AM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., McGregor A; London Northwest University Healthcare, Harrow, UK., Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Nana A; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Padayachee SD; Setshaba Research Centre, Pretoria, South Africa., Phillips DJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Pittella A; Hospital Quinta D'Or, Rede D'Or, Rio De Janeiro, Brazil., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Pollock KM; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ritchie AJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Schwarzbold AV; Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil., Smith A; College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital & School, University of Glasgow, Glasgow, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Sprinz E; Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Sutherland RK; Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK., Thomson EC; MRC-University of Glasgow Centre for Virus Research & Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK., Török ME; Department of Medicine, University of Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Toshner M; Heart Lung Research Institute, Dept of Medicine, University of Cambridge and NIHR Cambridge Clinical Research Facility, Cambridge University Hospital and Royal Papworth NHS Foundation Trusts, Cambridge, UK., Turner DPJ; University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK., Vekemans J; AstraZeneca BioPharmaceuticals, Cambridge, UK., Villafana TL; AstraZeneca BioPharmaceuticals, Cambridge, UK., White T; AstraZeneca BioPharmaceuticals, Cambridge, UK., Williams CJ; Public Health Wales, Cardiff, Wales; Aneurin Bevan University Health Board, Newport, Wales., Douglas AD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Hill AVS; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Lambe T; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbert SC; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.
Publikováno v:
Lancet (London, England) [Lancet] 2021 Mar 06; Vol. 397 (10277), pp. 881-891. Date of Electronic Publication: 2021 Feb 19.